News & Articles

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

Watch this on-demand webinar to gain insights into the design and development pipeline for rapid response solutions

Gain insight into how syndromic testing can improve pathogen detection, lead to better-informed treatment plans, and aid antimicrobial stewardship

In this guest editorial, discover the solutions that are driving the green revolution to make clinical laboratories more sustainable

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

The company seeks to become a global centre of excellence for whole genome sequencing

Clinical microbiology and virology expert shares her formula for success when diagnosing and treating conditions such as meningitis and encephalitis

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The drug aims to treat patients with myelodysplastic syndromes

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers